Phase 1 Preterm Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Recruiting
Phase 1
A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months
PreeclampsiasFlt1 Mediated Preterm PreeclampsiaPreterm Preeclampsia
Comanche Biopharma60 enrolled2 locationsNCT07282171
Recruiting
Phase 1Phase 2
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
PreeclampsiaPreterm Birth
Thomas Jefferson University400 enrolled1 locationNCT06826859
Recruiting
Phase 1
Cord blood therapy in premature babies: a safety and feasibility study
preterm brain injury
Monash Health20 enrolled1 locationACTRN12619001637134
Recruiting
Phase 1
Human Amnion Epithelial Cells for Prevention of Bronchopulmonary Dysplasia in Preterm Infants: A Safety Study
Bronchopulmonary DysplasiaExtremely preterm birth
Monash Health24 enrolled2 locationsACTRN12618000920291
Completed
Phase 1
Intravenous pentoxifylline as adjunct therapy in preterm infants with late-onset sepsis or necrotizing enterocolitis
Pentoxifylline pharmacokineticsPreterm infant
Tobias Strunk23 enrolled1 locationACTRN12616000219482
Completed
Phase 1
The effect of active chest physiotherapy techniques on regional ventilation on preterm infants on ventilatory support.
Preterm infants with respiratory disease on ventilatory support
Mater Health Services20 enrolled1 locationACTRN12606000211561
Completed
Phase 1
Determination of differential effects of 3 positions on lung function in preterm infants.
Preterm infants requiring ventilatory support
Mater Health Services54 enrolled1 locationACTRN12606000210572